Extracting Metallic Nanoparticles from Soils for Quantitative Analysis: Method Development Using Engineered Silver Nanoparticles and SP-ICP-MS von Schwertfeger, D. M, Velicogna, Jessica R, Jesmer, Alexander H, Saatcioglu, Selin, McShane, Heather, Scroggins, Richard P, Princz, Juliska I

Volltext

Single Particle-Inductively Coupled Plasma Mass Spectroscopy Analysis of Metallic Nanoparticles in Environmental Samples with Large Dissolved Analyte Fractions von Schwertfeger, D. M, Velicogna, Jessica R, Jesmer, Alexander H, Scroggins, Richard P, Princz, Juliska I

Volltext

Toxicity and metal bioaccumulation in Hordeum vulgare exposed to leached and nonleached copper amended soils von Schwertfeger, D.M., Hendershot, W.H.

Volltext

Ecotoxicological effects of copper oxide nanoparticles (nCuO) on the soil microbial community in a biosolids-amended soil von Samarajeewa, A.D., Velicogna, J.R., Schwertfeger, D.M., Princz, J.I., Subasinghe, R.M., Scroggins, R.P., Beaudette, L.A.

Volltext

Spike/Leach Procedure to Prepare Soil Samples for Trace Metal Ecotoxicity Testing: Method Development Using Copper von Schwertfeger, D M, Hendershot, W H

Volltext

Determination of Effective Cation Exchange Capacity and Exchange Acidity by a One-Step BaCl2 Method von Schwertfeger, Dina M, Hendershot, William H

Volltext

Comparing soil chemistries of leached and nonleached copper-amended soils von Schwertfeger, D.M., Hendershot, W.H.

Volltext

The toxicity of silver to soil organisms exposed to silver nanoparticles and silver nitrate in biosolids‐amended field soil von Jesmer, Alexander H., Velicogna, Jessica R., Schwertfeger, Dina M., Scroggins, Richard P., Princz, Juliska I.

Volltext

Cerium oxide nanoparticles (nCeO2) exert minimal adverse effects on microbial communities in soils with and without biosolids amendment von Dias Samarajeewa, Ajith, Velicogna, Jessica R., Schwertfeger, Dina M., Meier, Matthew J., Subasinghe, Renuka M., Princz, Juliska I., Scroggins, Rick P., Beaudette, Lee A.

Volltext

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients von Fleck, Christian, Janz, Alexander, Schweitzer, Frank, Karge, Elke, Schwertfeger, Markus, Stein, Gonter

Volltext

Effect of silver nanoparticle contaminated biosolids on the soil microbial community von Samarajeewa, Ajith Dias, Velicogna, Jessica R., Schwertfeger, Dina M., Jesmer, Alexander H., Princz, Juliska I., Subasinghe, Renuka M., Scroggins, Rick P., Beaudette, Lee A.

Volltext

Management of patients with peripheral arterial disease in primary care: a cross-sectional study in Germany von Kröger, K., Schwertfeger, M., Pittrow, D., Diehm, C.

Volltext

Treatment Satisfaction In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With Pact-Q2 At Baseline And 12-Month Follow-Up: Prefer In Af Registry von Brüggenjürgen, B, Schliephacke, T, Darius, H, De, Caterina R, Le, Heuzey J.Y, Reimitz, P.E, Schilling, R.J, Schwertfeger, M, Zamorano, J.L, Kirchhof, P

Volltext

Health State In Patients With Atrial Fibrillation On New Oral Anticoagulants As Assessed With The New Eq-5d-5l Questionnaire At Baseline And 12-Month Follow-Up: Prefer In Af Regist... von Brüggenjürgen, B, Schliephacke, T, Darius, H, De, Caterina R, Le, Heuzey J.Y, Reimitz, P.E, Schilling, R.J, Schwertfeger, M, Zamorano, J.L, Kirchhof, P

Volltext

Health State in Patients with Atrial Fibrillation on New Oral Anticoagulants as Assessed with the New EQ-5D-5L Questionnaire: Prefer in AF Registry von Brüggenjürgen, B, Ammentorp, B, Darius, H, De Caterina, R, Le-Heuzey, J.Y, Pittrow, D, Reimitz, P.E, Schilling, R.J, Schwertfeger, M, Zamorano, J.L, Kirchhof, P

Volltext

Treatment Satisfaction in Patients with Atrial Fibrillation on New Oral Anticoagulants as Measured with Pact-Q2: Prefer in AF Registry von Brüggenjürgen, B, Ammentorp, B, Darius, H, De Caterina, R, Le-Heuzey, J.Y, Pittrow, D, Reimitz, P.E, Schilling, R.J, Schwertfeger, M, Zamorano, J.L, Kirchhof, P

Volltext

Plasma levels of human growth differentiation factor 15 (GDF-15) and their effect of alirocumab on major adverse cardiovascular events and all-cause death after acute coronary synd... von Jukema, J, Van Neer, N J, Szarek, M, Cobbaert, C, Bittner, V A, Schwertfeger, M, Bhatt, D L, Fazio, S, Garon, G, Goodman, S G, Harrington, R A, Steg, P G, Stevanovic, I, White, H D, Schwartz, G G

Volltext

Two of a kind: mass and molar immunoassay-based lipoprotein (a) concentrations are similarly prognostic for MACE risk and predictive of alirocumab benefit in ODYSSEY OUTCOMES von Szarek, M, Steg, P G, Jukema, J W, Reijders, E, Schwertfeger, M, Bhatt, D, Bittner, V, Diaz, R, Fazio, S, Garon, G, Goodman, S G, Harrington, R A, White, H, Cobbaert, C, Schwartz, G G

Volltext

Regulation of renal amino acid (AA) transport by hormones, drugs and xenobiotics - a review von Fleck, C, Schwertfeger, M, Taylor, P M

Volltext

Regulation of L-leucine transport in rat kidney by dexamethasone and triiodothyronine von Schwertfeger, M, Pissowotzki, K, Fleck, Ch, Taylor, P. M

Volltext